COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Advances in Clinical Chemistry - 1st Edition - ISBN: 9780123858559, 9780123858566

Advances in Clinical Chemistry, Volume 53

1st Edition

Serial Editor: Gregory Makowski
Hardcover ISBN: 9780123858559
eBook ISBN: 9780123858566
Imprint: Academic Press
Published Date: 26th January 2011
Page Count: 200
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents


Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for multiplex genotyping

1. Abstract

2. Introduction

3. Genotyping Using Mass Spectrometry


5. Multiplex Genotyping by MALDI-TOF-MS

6. Conclusions

Rheumatic heart disease

1. Abstract

2. Rheumatic Heart Disease

3. Epidemiology

4. Genetic Susceptibility

5. Immune Mechanisms Involved in RHD

6. Rheumatic Heart Disease Lesions

7. Conclusions


Dipeptidyl peptidase in autoimmune pathophysiology

1. Abstract

2. Introduction

3. Molecular Aspects of CD26/DPPIV Role in Immunity

4. Cellular Aspects of CD26/DPPIV Role in Immunity

5. Clinical Aspects of CD26 Role in Immune Disorders

6. Summary and Perspective


Biochemistry of Hellp Syndrome

1. Abstract

2. Introduction

3. Pathogenesis of HELLP and Preeclampsia: The Role of Placenta

4. Inflammatory Response in HELLP Syndrome

5. HELLP Syndrome, Complement Pathway, and the Coagulation System

6. Conclusion

Homocysteine in Pregnancy

1. Abstract

2. Introduction

3. Homocysteine Metabolism

4. Prophylactic Folic Acid, Folate Status, and Homocysteine

5. Choline and Homocysteine

6. Nonnutritional Factors Associated with tHcy

7. Health Benefits of tHcy Lowering

8. Pregnancy


Diabetes and tuberculosis

1. Abstract

2. Introduction

3. Definition of the Problem

4. Analysis of Previous Experimental Results to Solve the Paradox

5. Probable Difference in Glycation Patterns of Macrophage Proteins and Its Precursors

6. In Silico Analysis of the Possibility of Glycation-Induced Inhibition of NADPH Oxidase

7. Solving the Paradox


EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment


2. Introduction

3. The Role of Tea Polyphenols in Carcinogenesis

4. In Vitro and In Vivo Preclinical Studies on Tea Polyphenols

5. Tea Polyphenols and Their Molecular Targets in Cancer Cells

6. Tea Polyphenol Derivatives in Cancer Studies

7. Conclusions



Volume 53 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to cutting-edge microarray technology.

Key Features

  • Leading experts from academia and clinical laboratory science
  • Volume emphasizes novel laboratory advances with application to clinical laboratory diagnostics and practical basic science studies


Biochemists and clinical biochemists


No. of pages:
© Academic Press 2011
26th January 2011
Academic Press
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Serial Editor

Gregory Makowski

Gregory Makowski

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.

Affiliations and Expertise

Clinical Laboratory Partners, Newington; Hartford Hospital, Hartford; Department of Laboratory Medicine, University of Connecticut Health Center, Farmington, CT, USA